First clinical application of a novel T1 mapping of the whole brain

Neuroradiol J. 2022 Dec;35(6):684-691. doi: 10.1177/19714009221084244. Epub 2022 Apr 21.

Abstract

Background: The aim of this study was to evaluate the reproducibility and clinical value of the novel single-shot T1 mapping method for rapid and accurate multi-slice coverage of the whole brain, described by Wang et al. 2015.

Methods: At a field strength of 3 Tesla, T1 mappings of 139 patients (51 of them without pathologic findings) and two repeats of five volunteers were performed at 0.5 mm in-plane resolution. Mean T1 values were determined in 18 manually segmented regions-of-interest without pathologic findings. Reproducibility of the repeated scans was calculated using mean coefficient of variations. Pathologies were grouped and separately evaluated.

Results: The mean age of the cohort was 49 (range 1-95 years). T1 relaxation times for ordinary brain and pathologies were in accordance with the literature values. Intra- and inter-subject reproducibility was excellent, and mean coefficient of variations were 2.4% and 3.8%, respectively.

Discussion: The novel rapid T1 mapping method is a reliable magnetic resonance imaging technique for identifying and quantifying normal brain structures and may thus serve as a basis for assessing pathologies. The fast and parallel online calculation enables a comfortable use in everyday clinical practice. We see a possible clinical value in a large spectrum of diseases, which should be investigated in further studies.

Keywords: T1 mapping; T1 relaxation time; quantitative magnetic resonance imaging.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Mapping
  • Brain* / diagnostic imaging
  • Brain* / pathology
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Magnetic Resonance Imaging* / methods
  • Middle Aged
  • Reproducibility of Results
  • Young Adult